Literature DB >> 19352617

[Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?].

M Brock1, W Martin, F Sommerer, J Noldus.   

Abstract

Ductal adenocarcinoma of the prostate is a rare entity. The lack of correlation between the prostate-specific antigen value and the tumor stage, as well as early dissemination, are major differences from acinar cancer. Due to a lack of early symptoms, the tumor is often found in an advanced stage. Urinary obstruction and hematuria lead to clinical assessment. The characteristic tumor growth near the seminal colliculus can yield a negative digital rectal examination. Despite a lack of treatment guidelines, authors recommend an aggressive surgical concept. First approaches include radical prostatectomy, transurethral resection, and high-dose radiotherapy. Subsequent androgen deprivation is recommended. We report the case of a 64-year-old man with ductal prostate cancer who underwent radical cystectomy followed by androgen deprivation therapy. This is the first such case reported in both the German and the English literature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352617     DOI: 10.1007/s00120-009-1968-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  13 in total

1.  Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings.

Authors:  Yun Gong; Nancy Caraway; John Stewart; Gregg Staerkel
Journal:  Am J Clin Pathol       Date:  2006-08       Impact factor: 2.493

2.  Retroperitoneal mucinous cystadenocarcinoma in a man: case report and review of the literature.

Authors:  Justin M Green; Bryan C Bruner; Wendell W Tang; Eduardo Orihuela
Journal:  Urol Oncol       Date:  2007 Jan-Feb       Impact factor: 3.498

3.  Endometrial carcinoma of proxtatic utricle (uterus masculinus).

Authors:  M M Melicow; M R Pachter
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

4.  Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.

Authors:  D A Brinker; S R Potter; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

5.  Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer.

Authors:  Dan Leibovici; Ashish M Kamat; Curtis A Pettaway; Lance Pagliaro; Charles J Rosser; Christopher Logothetis; Louis L Pisters
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

6.  Prostatic duct adenocarcinoma. Findings at radical prostatectomy.

Authors:  W N Christensen; G Steinberg; P C Walsh; J I Epstein
Journal:  Cancer       Date:  1991-04-15       Impact factor: 6.860

7.  Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings.

Authors:  D G Bostwick; R W Kindrachuk; R V Rouse
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394

8.  Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.

Authors:  Thomas N Eade; Tahseen Al-Saleem; Eric M Horwitz; Mark K Buyyounouski; David Y T Chen; Alan Pollack
Journal:  Cancer       Date:  2007-05-15       Impact factor: 6.860

9.  A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate.

Authors:  William H Tu; Kristin Jensen; Fuad Freiha; Joseph C Liao
Journal:  Nat Clin Pract Urol       Date:  2008-01

10.  "Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin.

Authors:  C Zaloudek; J W Williams; R L Kempson
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.